Login to Your Account

China's Ark teams up with Calibr on COPD to breathe new life into HNE inhibitors

By Shannon Ellis
Staff Writer

Tuesday, November 14, 2017

SHANGHAI – Shanghai-based Ark Biosciences Inc., a virtual biotech, and Calibr, of La Jolla, an affiliate of The Scripps Research Institute, one of the world's largest private biomedical research institutes, have partnered to develop preclinical assets for COPD.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription